STX19
gene geneOn this page
Also known as MGC21382
Summary
STX19 (syntaxin 19, HGNC:19300) is a protein-coding gene on chromosome 3q11.2, encoding Syntaxin-19 (Q8N4C7). Plays a role in endosomal trafficking of the epidermal growth factor receptor (EGFR).
Predicted to enable SNAP receptor activity and SNARE binding activity. Predicted to be involved in intracellular protein transport; synaptic vesicle fusion to presynaptic active zone membrane; and vesicle docking. Predicted to be located in cytoplasm and membrane. Predicted to be part of SNARE complex. Predicted to be active in endomembrane system and presynaptic active zone membrane.
Source: NCBI Gene 415117 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001001850
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19300 |
| Approved symbol | STX19 |
| Name | syntaxin 19 |
| Location | 3q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC21382 |
| Ensembl gene | ENSG00000178750 |
| Ensembl biotype | protein_coding |
| Entrez | 415117 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000315099, ENST00000856547, ENST00000856548, ENST00000944942, ENST00000944943, ENST00000944944
RefSeq mRNA: 1 — MANE Select: NM_001001850
NM_001001850
CCDS: CCDS33793
Canonical transcript exons
ENST00000315099 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001214978 | 94028367 | 94028597 |
| ENSE00001214989 | 94014365 | 94015282 |
Expression profiles
Bgee: expression breadth ubiquitous, 176 present calls, max score 88.01.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2565 / max 25.2535, expressed in 100 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 43306 | 0.1552 | 68 |
| 43307 | 0.0725 | 34 |
| 43308 | 0.0289 | 15 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 88.01 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 87.76 | gold quality |
| rectum | UBERON:0001052 | 85.54 | gold quality |
| colonic mucosa | UBERON:0000317 | 85.30 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 83.96 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 83.46 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.18 | gold quality |
| gingival epithelium | UBERON:0001949 | 82.57 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 81.42 | gold quality |
| gingiva | UBERON:0001828 | 80.63 | gold quality |
| body of pancreas | UBERON:0001150 | 79.19 | gold quality |
| esophagus mucosa | UBERON:0002469 | 78.39 | gold quality |
| parotid gland | UBERON:0001831 | 76.82 | silver quality |
| minor salivary gland | UBERON:0001830 | 76.48 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 76.44 | gold quality |
| mouth mucosa | UBERON:0003729 | 76.32 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 76.06 | gold quality |
| amniotic fluid | UBERON:0000173 | 75.28 | gold quality |
| transverse colon | UBERON:0001157 | 74.95 | gold quality |
| oral cavity | UBERON:0000167 | 74.03 | gold quality |
| pancreas | UBERON:0001264 | 73.85 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 72.73 | gold quality |
| skin of abdomen | UBERON:0001416 | 71.67 | gold quality |
| endometrium | UBERON:0001295 | 71.53 | gold quality |
| corpus epididymis | UBERON:0004359 | 70.78 | gold quality |
| jejunal mucosa | UBERON:0000399 | 70.68 | gold quality |
| body of stomach | UBERON:0001161 | 70.26 | gold quality |
| zone of skin | UBERON:0000014 | 70.13 | gold quality |
| skin of leg | UBERON:0001511 | 69.82 | gold quality |
| islet of Langerhans | UBERON:0000006 | 69.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.39 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Stx19 | ENSMUSG00000047854 |
| rattus_norvegicus | Stx19 | ENSRNOG00000070368 |
| caenorhabditis_elegans | WBGENE00006371 | |
| caenorhabditis_elegans | WBGENE00006372 | |
| caenorhabditis_elegans | WBGENE00006374 |
Paralogs (12): STX7 (ENSG00000079950), STX1B (ENSG00000099365), STX4 (ENSG00000103496), STX1A (ENSG00000106089), STX2 (ENSG00000111450), STX12 (ENSG00000117758), STX16 (ENSG00000124222), STX11 (ENSG00000135604), STX17 (ENSG00000136874), STX5 (ENSG00000162236), STX3 (ENSG00000166900), TSNARE1 (ENSG00000171045)
Protein
Protein identifiers
Syntaxin-19 — Q8N4C7 (reviewed: Q8N4C7)
All UniProt accessions (1): Q8N4C7
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in endosomal trafficking of the epidermal growth factor receptor (EGFR).
Subunit / interactions. Interacts with EGFR.
Subcellular location. Cell membrane. Cytoplasm.
Similarity. Belongs to the syntaxin family.
RefSeq proteins (1): NP_001001850* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000727 | T_SNARE_dom | Domain |
| IPR006011 | Syntaxin_N | Domain |
| IPR006012 | Syntaxin/epimorphin_CS | Conserved_site |
| IPR010989 | SNARE | Homologous_superfamily |
| IPR045242 | Syntaxin | Family |
Pfam: PF00804
UniProt features (2 total): chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N4C7-F1 | 78.14 | 0.23 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 81 (showing top):
GSE45365_NK_CELL_VS_BCELL_UP, CREL_01, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_VESICLE_ORGANIZATION, GOBP_MEMBRANE_FUSION, GOBP_NEUROTRANSMITTER_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_CELL_CELL_SIGNALING, GOBP_MEMBRANE_DOCKING, GOBP_EXOCYTOSIS, GOBP_VESICLE_FUSION_TO_PLASMA_MEMBRANE, GOBP_ORGANELLE_MEMBRANE_FUSION, GOBP_SECRETION, GOBP_SIGNAL_RELEASE, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION
GO Biological Process (5): intracellular protein transport (GO:0006886), exocytosis (GO:0006887), synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629), obsolete vesicle docking (GO:0048278), vesicle-mediated transport (GO:0016192)
GO Molecular Function (3): SNARE binding (GO:0000149), SNAP receptor activity (GO:0005484), protein binding (GO:0005515)
GO Cellular Component (6): plasma membrane (GO:0005886), endomembrane system (GO:0012505), SNARE complex (GO:0031201), presynaptic active zone membrane (GO:0048787), cytoplasm (GO:0005737), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| vesicle fusion to plasma membrane | 2 |
| intracellular protein localization | 1 |
| protein transport | 1 |
| intracellular transport | 1 |
| vesicle-mediated transport | 1 |
| secretion by cell | 1 |
| synaptic vesicle exocytosis | 1 |
| synaptic vesicle membrane organization | 1 |
| transport | 1 |
| cellular process | 1 |
| protein binding | 1 |
| protein-macromolecule adaptor activity | 1 |
| membrane fusion | 1 |
| fusogenic activity | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| vacuole | 1 |
| plasma membrane | 1 |
| cytoplasm | 1 |
| membrane protein complex | 1 |
| presynaptic membrane | 1 |
| presynaptic active zone | 1 |
| synaptic membrane | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
795 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STX19 | STXBP2 | Q15833 | 931 |
| STX19 | SNAP23 | O00161 | 930 |
| STX19 | UNC13D | Q70J99 | 870 |
| STX19 | RAB27A | P51159 | 777 |
| STX19 | VAMP8 | Q9BV40 | 768 |
| STX19 | STXBP5 | Q5T5C0 | 656 |
| STX19 | STXBP1 | P61764 | 648 |
| STX19 | VAMP7 | P51809 | 634 |
| STX19 | LYST | Q99698 | 609 |
| STX19 | PRF1 | P14222 | 580 |
| STX19 | STXBP5L | Q9Y2K9 | 566 |
| STX19 | VTI1B | Q9UEU0 | 558 |
| STX19 | VAMP4 | O75379 | 538 |
| STX19 | VAMP5 | O95183 | 530 |
| STX19 | VAMP3 | Q15836 | 526 |
IntAct
72 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STX19 | STXBP1 | psi-mi:“MI:0915”(physical association) | 0.850 |
| STXBP1 | STX19 | psi-mi:“MI:0915”(physical association) | 0.850 |
| STX19 | STXBP1 | psi-mi:“MI:0914”(association) | 0.850 |
| STX19 | PRKAB2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| PRKAB2 | STX19 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SYCE1 | STX19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | SYCE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PWP2 | STX19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | PWP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNAP25 | STX19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | NAPB | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | SUFU | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | SCNM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | ABI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | ZNF330 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | A2M | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | CHAT | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | DNM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX19 | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (61): STX19 (Two-hybrid), STX19 (Two-hybrid), STX19 (Two-hybrid), STXBP1 (Affinity Capture-MS), STXBP2 (Affinity Capture-MS), PRMT3 (Affinity Capture-MS), SNAP23 (Affinity Capture-MS), SULT1A2 (Affinity Capture-MS), STXBP5L (Affinity Capture-MS), STXBP5 (Affinity Capture-MS), TBK1 (Affinity Capture-MS), VAMP3 (Affinity Capture-MS), VAMP2 (Affinity Capture-MS), ZNF277 (Affinity Capture-MS), VAMP8 (Affinity Capture-MS)
ESM2 similar proteins: A8WVD0, O15400, O16000, O35526, O70257, O70439, P32850, P32851, P32856, P32867, P39926, P50279, P61264, P61265, P61266, P61267, P61268, P70452, Q00262, Q08849, Q08850, Q0VCI2, Q12846, Q13277, Q16623, Q16932, Q20024, Q24547, Q3SWZ3, Q3ZBT5, Q42374, Q59YF0, Q5R4L2, Q5R602, Q5TX47, Q64704, Q7XIE2, Q8N4C7, Q8R1Q0, Q8VZU2
Diamond homologs: A8WVD0, O15400, O16000, O35526, O64791, O65359, O75558, O94651, P32850, P32851, P32856, P32867, P39926, P50279, P61264, P61265, P61266, P61267, P61268, P70452, Q00262, Q08144, Q08849, Q08850, Q12846, Q13277, Q16623, Q16932, Q24547, Q3SWZ3, Q3ZBT5, Q42374, Q54JY7, Q54X86, Q59YF0, Q5R4L2, Q5RAL4, Q5TX47, Q64704, Q6F3B4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
419 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:94015282:CCTAA:C | acceptor_loss | 0.9800 |
| 3:94015283:C:CC | acceptor_gain | 0.9800 |
| 3:94015283:C:CG | acceptor_loss | 0.9800 |
| 3:94015284:T:G | acceptor_loss | 0.9800 |
| 3:94015280:CTC:C | acceptor_gain | 0.9700 |
| 3:94028362:TTTAC:T | donor_loss | 0.9600 |
| 3:94028363:TTA:T | donor_loss | 0.9600 |
| 3:94028364:TA:T | donor_loss | 0.9600 |
| 3:94028365:A:AG | donor_loss | 0.9600 |
| 3:94028366:C:CT | donor_loss | 0.9600 |
| 3:94028366:CCTTT:C | donor_gain | 0.9600 |
| 3:94023661:G:GA | donor_gain | 0.9300 |
| 3:94027522:A:AC | donor_gain | 0.9300 |
| 3:94027523:C:CC | donor_gain | 0.9300 |
| 3:94028380:T:TA | donor_gain | 0.9200 |
| 3:94017371:T:A | donor_gain | 0.9100 |
| 3:94026879:A:T | donor_gain | 0.8900 |
| 3:94016741:GGTT:G | donor_gain | 0.8800 |
| 3:94015278:TCCTC:T | acceptor_gain | 0.8600 |
| 3:94015279:CCTCC:C | acceptor_gain | 0.8600 |
| 3:94015285:A:C | acceptor_loss | 0.8600 |
| 3:94027946:GTTA:G | donor_gain | 0.8600 |
| 3:94027947:TTAT:T | donor_gain | 0.8600 |
| 3:94023660:T:TA | donor_gain | 0.8500 |
| 3:94026880:A:AC | donor_gain | 0.8500 |
| 3:94026881:C:CC | donor_gain | 0.8500 |
| 3:94027519:A:AC | donor_gain | 0.8500 |
| 3:94027524:A:C | donor_gain | 0.8400 |
| 3:94028132:T:A | donor_gain | 0.8300 |
| 3:94015281:TCCTA:T | acceptor_gain | 0.8100 |
AlphaMissense
1971 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:94014767:C:G | R168P | 0.983 |
| 3:94014966:C:G | A102P | 0.980 |
| 3:94014614:A:G | L219P | 0.979 |
| 3:94014644:A:G | L209P | 0.979 |
| 3:94014458:G:T | A271D | 0.978 |
| 3:94014761:A:G | L170P | 0.977 |
| 3:94014625:T:A | R215S | 0.963 |
| 3:94014625:T:G | R215S | 0.963 |
| 3:94014459:C:G | A271P | 0.962 |
| 3:94015012:A:C | S86R | 0.956 |
| 3:94015012:A:T | S86R | 0.956 |
| 3:94015014:T:G | S86R | 0.956 |
| 3:94014571:G:C | F233L | 0.955 |
| 3:94014571:G:T | F233L | 0.955 |
| 3:94014573:A:G | F233L | 0.955 |
| 3:94014688:A:C | F194L | 0.955 |
| 3:94014688:A:T | F194L | 0.955 |
| 3:94014690:A:G | F194L | 0.955 |
| 3:94015259:C:G | R4P | 0.955 |
| 3:94015247:A:G | L8P | 0.954 |
| 3:94014699:A:G | W191R | 0.951 |
| 3:94014699:A:T | W191R | 0.951 |
| 3:94014775:A:C | F165L | 0.950 |
| 3:94014775:A:T | F165L | 0.950 |
| 3:94014777:A:G | F165L | 0.950 |
| 3:94014575:A:G | L232P | 0.934 |
| 3:94014623:T:G | H216P | 0.934 |
| 3:94014626:C:G | R215T | 0.930 |
| 3:94014768:G:T | R168S | 0.930 |
| 3:94014753:C:G | A173P | 0.929 |
dbSNP variants (sampled 300 via entrez): RS1000135023 (3:94016935 G>A,T), RS1000217913 (3:94026304 T>G), RS1000486203 (3:94017303 G>A,T), RS1000600441 (3:94020456 C>A,G), RS1000754263 (3:94026625 G>A,C), RS1000797888 (3:94019650 A>G), RS1000887526 (3:94026045 A>G), RS1001143754 (3:94020231 T>A), RS1001177956 (3:94028441 T>C), RS1001247204 (3:94016490 A>G), RS1001267049 (3:94023427 A>G), RS1001412648 (3:94018268 T>A), RS1001416433 (3:94029916 G>A), RS1001544968 (3:94015497 G>A,T), RS1001801810 (3:94023014 A>G)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:612291
GenCC curated gene-disease
Mondo (1): Joubert syndrome 8 (MONDO:0012855)
Orphanet (1): Isolated Joubert syndrome (Orphanet:475)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C567358 | Joubert Syndrome 8 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| avobenzone | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Nickel | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Joubert syndrome 8